Latest Insider Transactions at Crispr Therapeutics Ag (CRSP)
This section provides a real-time view of insider transactions for Crispr Therapeutics Ag (CRSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CRISPR Therapeutics AG to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CRISPR Therapeutics AG's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 19
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
248,625
+31.17%
|
-
|
Feb 19
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
171,003
-12.77%
|
$25,479,447
$149.99 P/Share
|
Jan 19
2021
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
27,500
-14.51%
|
$5,637,500
$205.45 P/Share
|
Jan 19
2021
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
27,500
+35.52%
|
$1,402,500
$51.49 P/Share
|
Jan 15
2021
|
Lawrence Otto Klein CBO & COO |
SELL
Open market or private sale
|
Direct |
25,000
-6.68%
|
$5,375,000
$215.28 P/Share
|
Jan 15
2021
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,010
+27.12%
|
$325,130
$13.5 P/Share
|
Jan 15
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.71%
|
$4,280,000
$214.49 P/Share
|
Jan 15
2021
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.97%
|
$20,000
$1.81 P/Share
|
Jan 02
2021
|
Lawrence Otto Klein CBO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,392
-46.96%
|
$1,436,976
$153.11 P/Share
|
Dec 29
2020
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,800
+7.01%
|
$13,800
$1.81 P/Share
|
Dec 21
2020
|
Tony W Ho Executive VP, Head of R&D |
SELL
Open market or private sale
|
Direct |
23,551
-5.54%
|
$3,509,099
$149.69 P/Share
|
Dec 21
2020
|
Tony W Ho Executive VP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
23,551
+29.05%
|
$376,816
$16.9 P/Share
|
Dec 16
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
7,352
-0.43%
|
$1,095,448
$149.12 P/Share
|
Dec 16
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
7,648
-50.79%
|
$1,139,552
$149.12 P/Share
|
Dec 10
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
33,000
-1.97%
|
$4,686,000
$142.54 P/Share
|
Dec 10
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-2.2%
|
$2,840,000
$142.92 P/Share
|
Dec 10
2020
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.56%
|
$20,000
$1.81 P/Share
|
Dec 09
2020
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
22,026
+49.56%
|
$286,338
$13.62 P/Share
|
Dec 07
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
171,004
-2.08%
|
$26,334,616
$154.02 P/Share
|
Dec 01
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
779
-0.46%
|
$100,491
$129.58 P/Share
|
Nov 30
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
100,000
-7.16%
|
$12,500,000
$125.0 P/Share
|
Nov 30
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+6.68%
|
$1,400,000
$14.22 P/Share
|
Oct 29
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
18,477
+31.25%
|
-
|
Oct 29
2020
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
518,519
-49.0%
|
-
|
Oct 29
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
105,681
+50.0%
|
-
|
Oct 09
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
2,762
-0.42%
|
$276,200
$100.0 P/Share
|
Oct 09
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,762
+0.42%
|
$38,668
$14.43 P/Share
|
Oct 08
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
22,238
-3.32%
|
$2,223,800
$100.0 P/Share
|
Oct 08
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
22,238
+3.21%
|
$311,332
$14.43 P/Share
|
Sep 22
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
14,780
+40.0%
|
-
|
Sep 22
2020
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
414,816
-43.89%
|
-
|
Sep 22
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
84,544
+50.0%
|
-
|
Sep 18
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
3,035
-0.58%
|
$261,010
$86.87 P/Share
|
Sep 16
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
8,965
-1.69%
|
$770,990
$86.98 P/Share
|
Sep 14
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
1,155
-0.22%
|
$97,020
$84.89 P/Share
|
Sep 10
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
22,845
-2.08%
|
$1,941,825
$85.47 P/Share
|
Sep 09
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
7,391
+50.0%
|
-
|
Sep 09
2020
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
207,408
-38.22%
|
-
|
Sep 09
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
42,272
+50.0%
|
-
|
Sep 02
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
779
-0.46%
|
$73,226
$94.15 P/Share
|
Sep 01
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
25,000
-1.25%
|
$2,300,000
$92.44 P/Share
|
Sep 01
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+1.82%
|
$350,000
$14.22 P/Share
|
Sep 01
2020
|
Michael John Tomsicek Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,000
-58.8%
|
$1,104,000
$92.27 P/Share
|
Sep 01
2020
|
Michael John Tomsicek Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+49.16%
|
$204,000
$17.75 P/Share
|
Sep 01
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
60,000
-67.85%
|
$5,520,000
$92.6 P/Share
|
Sep 01
2020
|
Bradley J Ph D Bolzon Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
60,000
+31.67%
|
$1,680,000
$28.98 P/Share
|
Aug 19
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
25,000
-3.71%
|
$2,500,000
$100.0 P/Share
|
Aug 19
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.58%
|
$350,000
$14.0 P/Share
|
Aug 13
2020
|
Ali Behbahani |
BUY
Other acquisition or disposition
|
Indirect |
14
+50.0%
|
-
|
Aug 13
2020
|
Ali Behbahani |
BUY
Other acquisition or disposition
|
Direct |
57
+18.21%
|
-
|